EMEA-000178-PIP01-07-M04

Key facts

Invented name
Pumarix
Active substance
Purified antigen fractions of inactivated split virion Influenza A/Indonesia/05/2005(H5N1) like strain used (PR8-IBCDC-RG2)
Therapeutic area
Vaccines
Decision number
P/0088/2015
PIP number
EMEA-000178-PIP01-07-M04
Pharmaceutical form(s)
Emulsion and suspension for emulsion for injection
Condition(s) / indication(s)
Prevention of influenza infection
Route(s) of administration
Intramuscular use
Contact for public enquiries
GlaxoSmithKline Biologicals S.A. (Belgium)

Belgium
Tel. +32 10859472
Fax +32 10858194
E-mail: rix.eudralink@gskbio.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating